![Shaan Gandhi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shaan Gandhi
Direttore/Membro del Consiglio presso
Triumvira Immunologics, Inc.
Profilo
Shaan C.
Gandhi is the founder of Pyxis Oncology, Inc. (founded in 2018) where he held the title of President & Director.
He is currently a Director at Triumvira Immunologics, Inc., StrideBio, Inc., Northpond Ventures LLC, DICE Molecules SV, Inc., Mestag Therapeutics Ltd., Totus Medicines, Inc., Garuda Therapeutics, Inc., Incendia Therapeutics, Inc., and Transition Bio, Inc. He previously served as an Independent Director at Candel Therapeutics, Inc. (2020-2022) and DICE Therapeutics, Inc. (2020-2023).
He also held positions as a Director at Teckro, Inc., Aro Biotherapeutics Co., and Kyverna Therapeutics, Inc. Additionally, he was an Independent Director at Vigil Neuroscience, Inc. (2020-2023) and a Director at CAMP4 Therapeutics Corp.
Dr. Gandhi obtained a doctorate degree from the University of Oxford and Harvard Medical School.
He also holds an undergraduate degree from Case Western Reserve University and an MBA from Harvard Business School (2015).
Posizioni attive di Shaan Gandhi
| Società | Posizione | Inizio |
|---|---|---|
Northpond Ventures LLC
 Northpond Ventures LLC Investment ManagersFinance Northpond Ventures invests in companies located in the United States. The firm focuses on the science and technology sectors. It participates in early-stage capital transactions. | Direttore/Membro del Consiglio | 01/01/2020 |
DICE Molecules SV, Inc.
 DICE Molecules SV, Inc. Investment ManagersFinance Functions as an alternative investment manager | Direttore/Membro del Consiglio | 01/01/2020 |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Direttore/Membro del Consiglio | 01/01/2021 |
Triumvira Immunologics, Inc.
 Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Direttore/Membro del Consiglio | 01/01/2020 |
Garuda Therapeutics, Inc.
 Garuda Therapeutics, Inc. BiotechnologyHealth Technology Develops hematopoietic stem cell therapies to treat severe and life-threatening diseases | Direttore/Membro del Consiglio | 01/01/2021 |
Incendia Therapeutics, Inc.
 Incendia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel class of anti-cancer therapies | Direttore/Membro del Consiglio | - |
Mestag Therapeutics Ltd.
 Mestag Therapeutics Ltd. Financial ConglomeratesFinance Provides investment services | Direttore/Membro del Consiglio | - |
Totus Medicines, Inc.
 Totus Medicines, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs for cancer patients | Direttore/Membro del Consiglio | - |
Transition Bio, Inc.
 Transition Bio, Inc. BiotechnologyHealth Technology Provides condensate technology for drug discovery and diagnostics | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Shaan Gandhi
| Società | Posizione | Fine |
|---|---|---|
| ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Formazione di Shaan Gandhi
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
86
Relazioni di 1° grado
22
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 22 |
|---|---|
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology Develops oral immunology and other therapeutic products | Health Technology |
Teckro, Inc.
 Teckro, Inc. Packaged SoftwareTechnology Services Develops clinical trial software | Technology Services |
Triumvira Immunologics, Inc.
Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
StrideBio, Inc.
StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Health Technology |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
Northpond Ventures LLC
Northpond Ventures LLC Investment ManagersFinance Northpond Ventures invests in companies located in the United States. The firm focuses on the science and technology sectors. It participates in early-stage capital transactions. | Finance |
Aro Biotherapeutics Co.
 Aro Biotherapeutics Co. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics | Health Technology |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Kyverna Therapeutics, Inc.
 Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
Mestag Therapeutics Ltd.
Mestag Therapeutics Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Vigil Neuroscience, Inc.
 Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
Totus Medicines, Inc.
Totus Medicines, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs for cancer patients | Health Technology |
Garuda Therapeutics, Inc.
Garuda Therapeutics, Inc. BiotechnologyHealth Technology Develops hematopoietic stem cell therapies to treat severe and life-threatening diseases | Health Technology |
Incendia Therapeutics, Inc.
Incendia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel class of anti-cancer therapies | Health Technology |
Transition Bio, Inc.
Transition Bio, Inc. BiotechnologyHealth Technology Provides condensate technology for drug discovery and diagnostics | Health Technology |
